ORPHA:254492
Frontal fibrosing alopecia
Also known as: FFA
Publications
1,305
Trials
13
Interventional, condition-specific
Researchers
803
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
Frontal fibrosing alopecia (FFA) is a rare variant of lichen planopilaris characterized by symmetrical, , band-like anterior hair loss of the scalp.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0016776
- UMLS:C4255374
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
1,305 matched papers (1,071 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
13 matched on ClinicalTrials.gov (3 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
1,305
1,305 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
1,305 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
1,071 in the last 10 years · low confidence
Phrase hits: 1,305 · MeSH hits: 0
Who's working on it?
803
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Saceda-Corralo D12 papers · 2026
Dermatology Department, University Hospital Ramon y Cajal and IRYCIS, Universidad de Alcala, Madrid, Spain.
Papers in Europe PMC - 02Shapiro J12 papers · 2026
The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
Papers in Europe PMC - 03Tosti A12 papers · 2026
Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 1600 N.W. 10th Avenue, RMSB, Room 2023-A, Miami, FL, USA.
Papers in Europe PMC - 04Lo Sicco KI9 papers · 2026
The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
Papers in Europe PMC - 05Senna MM9 papers · 2026
Department of Dermatology, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
Papers in Europe PMC - 06Piraccini BM8 papers · 2026
Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S Orsola-Malpighi, Bologna, Italy.
Papers in Europe PMC - 07Donovan J6 papers · 2026
Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
Papers in Europe PMC - 08Melo DF6 papers · 2026
Department of Dermatology, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Papers in Europe PMC - 09Chen LC5 papers · 2026
Department of Dermatology, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
Papers in Europe PMC - 10Ezzat RZ5 papers · 2026
Georgetown University School of Medicine, Washington, District of Columbia.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
13
interventional trials for this specific condition
13 interventional trials matched this specific condition name; 3 currently recruiting in our sample. 508 trials are registered for alopecia, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
13 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 92.8th percentile).
low confidence · 92.8th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
13 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT07508488·RECRUITING·Deucravacitinib in the Treatment of Cicatricial Alopecias
Conditions: Central Centrifugal Cicatricial Alopecia · Frontal Fibrosing Alopecia·Matched via name phrase
- NCT07340671·RECRUITING·Facial Papules in Frontal Fibrosing Alopecia (FFA)
Conditions: Frontal Fibrosing Alopecia·Matched via name phrase
- NCT07671157·NOT YET RECRUITING·Phase 2 Open Label Trial of Delgocitinib 20 mg/g Cream in Subjects With Frontal Fibrosing Alopecia (FFA)
Conditions: Frontal Fibrosing Alopecia·Matched via name phrase
Broader category: alopecia
508
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06747611·RECRUITING·Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
Conditions: Alopecia Areata · Alopecia Totalis · Alopecia Universalis·Matched via name phrase
- NCT07429253·RECRUITING·Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients
Conditions: Androgenetic Alopecia·Matched via name phrase
- NCT07381556·RECRUITING·Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study
Conditions: Alopecia Areata(AA) · Alopecia Areata (AA) · Alopecia Totalis/Universalis · Alopecia Universalis (AU)·Matched via name phrase
- NCT05888922·RECRUITING·Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Conditions: Androgenetic Alopecia · Female Pattern Baldness·Matched via name phrase
- NCT05398809·RECRUITING·Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
Conditions: Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced) · Alopecia Areata·Matched via name phrase
- NCT06786078·RECRUITING·The Lily Device Trial
Conditions: Chemotherapy Induced Alopecia·Matched via name phrase
- NCT07705217·NOT YET RECRUITING·The Role of Gut and Skin Microbiota in Alopecia Areata
Conditions: Alopecia Areata · Fecal Microbiota Transplantation (FMT) · T Cell Subsets · Microbiome·Matched via name phrase
- NCT07618195·RECRUITING·Study of EPI-001 in Patients With Androgenetic Alopecia
Conditions: Androgenetic Alopecia·Matched via name phrase
- NCT06916793·NOT YET RECRUITING·A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia
Conditions: Androgenetic Alopecia·Matched via name phrase
- NCT06564805·RECRUITING·Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata
Conditions: Alopecia Areata·Matched via name phrase
- NCT06012240·RECRUITING·A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Conditions: Alopecia Areata·Matched via name phrase
- NCT07588243·RECRUITING·A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth
Conditions: Androgenic Alopecia·Matched via name phrase
- NCT07018349·NOT YET RECRUITING·Low Dose Oral Minoxdil in Androgenic Alopecia
Conditions: Androgenetic Alopecia (AGA)·Matched via name phrase
- NCT07029204·RECRUITING·Intralesional Cyclosporine for Alopecia Areata
Conditions: Alopecia Areata·Matched via name phrase
- NCT04207931·RECRUITING·Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
Conditions: Central Centrifugal Cicatricial Alopecia (CCCA)·Matched via name phrase
Observational and natural-history studies
4 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07190534·NOT YET RECRUITING·The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Frontal Fibrosing Alopecia in Routine Clinical Care: a Patient Preference Trial (FFA Trial)
Conditions: Frontal Fibrosing Alopecia · Cicatricial Alopecia·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Frontal fibrosing alopecia"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Frontal fibrosing alopecia"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 13 interventional · 4 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"alopecia"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: FFA
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (1305) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T11:04:03.462Z
